Yohei Okada

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové

Publication